Evidence map›Paper›PMID 41189528›Full record

ReviewTransfusion medicine (Oxford, England)2026

A blood safety perspective on emerging arboviral infections in the United Kingdom.

Piya Rajendra, Shannah Secret, Su Brailsford, Tanya Golubchik, Peter Simmonds, Heli Harvala

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Transfusion medicine (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Piya RajendraRadcliffe Department of Medicine, University of Oxford, Oxford, UK.
Shannah SecretRadcliffe Department of Medicine, University of Oxford, Oxford, UK.
Su BrailsfordMicrobiology Services, NHS Blood and Transplant, Colindale, UK.
Tanya GolubchikBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Peter SimmondsNuffield Department of Medicine, University of Oxford, Oxford, UK.
Heli HarvalaRadcliffe Department of Medicine, University of Oxford, Oxford, UK.

Funding

National Institutes for Health and Care Research NIHR203338
6 · The paper itself

Abstract

A core focus of the blood services is to maintain the blood supply whilst simultaneously being vigilant for potential threats to blood safety. At present, West Nile virus (WNV), Usutu virus (USUV), Dengue virus (DENV) and Tick-borne encephalitis virus (TBEV) are considered primary arboviral threats to blood safety in the UK and Northern Europe. Climate change and globalisation have enhanced the frequency of WNV and DENV cases being reported in Europe, furthering the likelihood of their spread to the UK. Furthermore, both TBEV and USUV have already been identified in reservoir hosts in England and the first human cases of TBEV infections acquired in England have been recently documented. Existing policy to protect the blood supply against emerging viral risks is based on donor deferral or nucleic acid test (NAT) screening for those recently returning from WNV endemic areas, only. Constant evaluation of the current policy is necessary to assess the feasibility of donor deferral if the case numbers within Europe continue to increase, and to determine if selective screening for these viruses is needed. Regardless of the testing and prevention strategies decided upon by the blood services, frequent review of these policies will be necessary to reflect the national and wider disease epidemiology of these arboviral infections.

Indexed as

Arbovirus InfectionsBlood SafetyCommunicable Diseases, EmergingBlood DonorsHumansUnited KingdomWest Nile Feverarbovirusesblood safetyDengue virusemerging infectionsTick‐borne encephalititis virusUsutu virusWest Nile virus

Identifiers

PMID41189528
PMCPMC12882747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.